SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-029501
Filing Date
2020-10-28
Accepted
2020-10-28 16:15:09
Documents
1
Period of Report
2020-10-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5708
  Complete submission text file 0000899243-20-029501.txt   7245
Mailing Address DURATA THERAPEUTICS, INC. 89 HEADQUARTERS PLAZA NORTH, 14TH FLOOR MORRISTOWN NJ 07960
Business Address
Dunne Michael W. (Reporting) CIK: 0001553593 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38503 | Film No.: 201268813

Mailing Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2
Business Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2 (872) 225-6077
Iterum Therapeutics plc (Issuer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences